openPR Logo
Press release

Flu diagnosis set to be revolutionised by Enigma ML system

09-30-2013 10:38 AM CET | Science & Education

Press release from: Ploughshare Innovations Ltd.

Flu diagnosis set to be revolutionised by Enigma ML system

Enigma Diagnostics Ltd, a spin-out company of Ploughshare Innovations, has successfully completed its analytical and diagnostic verification of its FluAB-RSV diagnostic assay on the Enigma® ML system, which looks set to benefit many patients in the future.
The organisation – which specialises in developing next generation rapid molecular diagnostic instrument platforms for decentralised and point-of-care settings – completed the verification at Guy’s and St. Thomas’ NHS Foundation Trust in London, and is set to finalise validation and CE marking of the test this year.
Enigma installed a series of mini laboratory (ML) instruments at Guy’s and St. Thomas’ for use at the Trust’s Centre for Clinical Infection and Diagnostics Research (CIDR). Over the last few months, hundreds of clinical samples obtained from respiratory disease patients in Africa, were processed on the Enigma® ML system and compared with data from the Luminex xTAG respiratory viral panel.
The results highlighted comparable sensitivity and specificity between the two systems with the Enigma® ML achieving negative predictive value (NPV) and positive predictive value (PPV) values of 100 per cent for the FluB and respiratory syncytial virus (RSV) components of the assay. The system also achieved NPV and PPV of 97 per cent and 100 per cent for the FluA component of the assay.
The Enigma® ML system is able to deliver PCR-based results from a raw sample over a time period of around one hour and the organisation is also working on the development of a series of multiplexed assays for the Enigma® ML – including panel tests for respiratory viruses, multi-drug resistant tuberculosis and other respiratory infections – in addition to the FluAB-RSV test.
Chairman of Enigma Diagnostics, John McKinley, said that the organisation was “delighted to be collaborating with such a prestigious and influential clinical centre.”
“Having achieved such an exceptional diagnostic performance on our Enigma® ML system with the FluAB-RSV assay, we are now ready for validation and CE marking,” Mr McKinley went on to say.
Consultant Microbiologist and Head of the Centre for Clinical Infection and Diagnostics Research at Guy’s and St. Thomas’, Dr Jonathan Edgeworth, said that the hospital was extremely pleased that Enigma had chosen it as its partner to test the performance of the Enigma® ML system.
“This will provide an opportunity to influence the development of a testing system that has potential to benefit patients in the future,” Mr Edgeworth concluded.

Ploughshare Innovations Ltd
www.ploughshareinnovations.com
Ploughshare manages the commercial licencing to industry of Intellectual Property developed by the Defence Science and Technology Laboratory (Dstl). Ploughshare’s goal is to give clients a competitive edge, by lowering technology risk, reducing R&D costs, speeding time to market, and maximizing the business opportunity. It provides leading edge, application focused technology, backed up with the assurance of advanced IP support and protection. Ploughshare is a wholly owned subsidiary of Dstl. Dstl maximises the impact of science and technology for the defence and security of the UK. It supplies sensitive and specialist science and technology services for the UK Ministry of Defence and wider government, saving lives in the UK, overseas and on the frontline.
Enigma Diagnostics Limited
www.enigmadiagnostis.com
Enigma works to provide cost-effective, straightforward molecular diagnostics at the point of need and specialises in developing next-generation rapid molecular diagnostic instrument platforms for laboratories and decentralized point-of-need settings. Enigma’s innovation and proprietary technologies combine the speed and sensitivity of real-time PCR (polymerase chain reaction) with the simplicity needed for decentralized and point-of-need testing providing results from a raw sample in under 60 minutes.

Ploughshare Innovations Ltd.
Unit 2, Nine Mile Water Business Park
Nether Wallop, Stockbridge
Hampshire SO20 8DR
United Kingdom
T: +44 (0) 1794 301602
http://www.ploughshareinnovations.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Flu diagnosis set to be revolutionised by Enigma ML system here

News-ID: 267745 • Views: 1864

More Releases from Ploughshare Innovations Ltd.

P2I Previews Advanced IPX7 Dunkable™ Technology at Mobile World Congress
With millions of users already benefiting from the company's splashproof liquid repellent nano-coating on Motorola and TCL Communication smartphones and tablets, P2i is unveiling its new, Dunkable™ technology at Mobile World Congress. Hampshire, UK, February 28, 2013 - Dunkable™ is a game-changing hydrophobic barrier which allows electronics to function in liquids for an extended period of time. Differentiating itself from the splashproof technology, which is a hydrophobic layer approximately 1000 times
MOD Spin-out Receives CA £500K Funding for Technology
ProKyma, a spin-out from the Defence Science and Technology Laboratory (Dstl) and founded by Ploughshare Innovations, today announced a £482K grant from the National Institute for Health Research (NIHR) i4i programme. Hampshire, UK, December 18, 2012 - ProKyma, a spin-out from the Defence Science and Technology laboratory (Dstl) and founded by Ploughshare Innovations, today announced a £482K grant from the National Institute for Health Research (NIHR) i4i programme. The funding will

More Releases for Enigma

Unleash the enigma in Hematology/ Oncology through World Hematology 2018
May 10th, 2018: Pulsus Group hosts the 10th World Hematology and Oncology Congress (World Hematology 2018) that discusses the new paradigm approach to probe every single element in Hematology/ Oncology. World Hematology 2018 focuses on many interactive scientific sessions on different types of Blood disorders and Cancers as well as various diagnostic and therapeutic advancements in this field. It also provides an opportunity to showcase your ingenuity to the world.
Home Service Validation System-A Social Enigma
[The “HOME SERVICE VALIDATION SYSTEM” is a rare American, unexplored, ultra-conservative home improvement contractor screening alternative Introduction [Among the leading reasons for most contract-related home maintenance and improvement improprieties in America is that private home decision makers neglect doing the necessary research on contractors. The "HOME SERVICE VALIDATION SYSTEM" can be enormously instrumental in changing that. It all begins with the "SERVICE VALIDATION FORM"] There is a website (match heading) where
Enigma Software Group Presses New French Lawsuit Claims Against Malwarebytes
PARIS, FRANCE, January 11, 2018 − Enigma Software Group USA, LLC ("ESG") has initiated a lawsuit against Malwarebytes Inc. and Malwarebytes Limited (Malwarebytes) in the Commercial Court of Paris over Malwarebytes' unlawful, predatory business practices in France, which are hurting French consumers and ESG. ESG's lawsuit against Malwarebytes asserts claims under French law for Malwarebytes' unlawful conduct of falsely labeling ESG's programs as "potentially unwanted programs" and blocking and interfering
Enigma Software Group Responds to Malwarebytes Incompatibility
CLEARWATER, FL, December 20, 2016 − Enigma Software Group USA, LLC ("ESG") began notifying its customers that Malwarebytes Inc., the maker of Malwarebytes Anti-Malware ("MBAM") and AdwCleaner, has begun intentionally blocking the installation and operation of ESG's programs SpyHunter and RegHunter for what ESG believes are competitive reasons. This action by Malwarebytes has created an immediate incompatibility between SpyHunter or RegHunter coexisting on the same PC with MBAM. Independent third-party certification
Enigma Software Group’s SpyHunter® Receives Top Score from AV-TEST
CLEARWATER, FL, December 01, 2016 − Enigma Software Group USA, LLC ("ESG") announced today that its flagship product, SpyHunter® anti-malware, received a top score from AV-TEST GmbH, also known as the "AV-TEST Institute," is a leading international and independent service provider in the fields of IT security and anti-virus research. AV-TEST Institute explains that the aim of its research work is to directly detect the latest malware, to analyze it
Enigma Software Group Files Suit Against Malwarebytes
CLEARWATER, FL, October 7, 2016 − Enigma Software Group USA, LLC (ESG) filed a complaint in federal court in New York today against competing anti-malware provider Malwarebytes Inc. The complaint, available here, alleges false advertising, unfair competition, and tortious interference with contractual relations. The complaint alleges that Malwarebytes this week began improperly detecting and reporting to consumers that ESG's anti-malware product SpyHunter® and ESG's registry cleaner product RegHunter® were Potentially Unwanted